Dubai: Agiomix FZ-LLC; the next generation sequencing and molecular genetics lab in Dubai received its Dubai Health Authority (DHA) license on 18th June 2019, the lab at the Dubai Science Park was inspected by the DHA team for quality and compliance with the DHA licensing requirements and was found to be in conformance with all the required policies, guidelines and regulations to receive the DHA license.
The DHA licensing process is designed to ensure onsite facility design, quality of services, and safety of the professionals in accordance with the local laws whilst maintaining international quality standards of service. The Authority examines and scrutinizes all aspects of offering healthcare service, such as laboratory protocols, equipment, staff, safety programs, record ensure compliance with DHA regulatory requirements, and the United Arab Emirates (UAE) federal laws.
Following this successful licensing, Dr. Walid Dridi, the Medical Director of Agiomix said, “This is a great step of confirmation of our internal quality standards, it also gives us the opportunity to start serving the populations of the United Arab Emirates and the region with our genetic and molecular assays and services.”
About Agiomix FZ-LLC
Agiomix FZ-LLC is a Dubai-headquartered genomics company, focused on offering sequencing and genotyping services to research and clinical customers. Agiomix strives to offer localized, high standard and affordable genomics analysis services with unparalleled counseling and support.
© Press Release 2019